NYSE · Specialty Business Services

Attovia Therapeutics, Inc. (ATTO) Stock

$13.73 -7.10% NYSE: ATTO Industrials

Valuation

Metric	Value
Price	$13.73
Market Cap	$626.79M
P/E Ratio	-23.81
P/B Ratio	8.96
P/S Ratio	2117.08
EPS (TTM)	$-6.41
52-Week High	$28.00
52-Week Low	$13.56
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-32.05%
ROA	-30.65%
ROCE	10.43%
Gross Margin	93.53%
Operating Margin	5.00%
Net Margin	-6.21%
Debt/Equity	0.04
Current Ratio	1.24

Annual Financials (USD)

Metric	2017	2018	2019	2020	2021
Revenue	$1.9B	$1.8B	$1.7B	$1.4B	$1.4B
Operating Profit	$92.0M	$90.0M	$64.0M	$56.0M	$73.0M
Net Profit	$-17.0M	$19.0M	$-81.0M	$-47.0M	$-90.0M
EPS	$-1.14	$1.24	$-5.59	$-3.32	$-6.41
Op Margin	4.8%	4.9%	3.7%	4.0%	5.0%

Balance Sheet (USD)

Metric	2017	2018	2019	2020	2021
Total Assets	$1.3B	$1.2B	$1.3B	$1.2B	$1.1B
Total Liabilities	$953.0M	$873.0M	$1.1B	$1.1B	$1.1B
Cash	$142.0M	$134.0M	$125.0M	$209.0M	$129.0M
Borrowings	$486.0M	$460.0M	$721.0M	$727.0M	$718.0M

Latest News

Omilia Appoints Armando Trivellato as EVP Growth Latin America and Iberia Business Wire · Jul 2, 2026 Atento and Cresta Sign Strategic Partnership to Deliver Hybrid Human-AI Customer Experience Solutions PR Newswire · May 7, 2026

Cash Flow (USD)

Metric	2017	2018	2019	2020	2021
Operating Cash Flow	$114.0M	$81.0M	$46.0M	$128.0M	$42.0M
Investing Cash Flow	$-168.0M	$-81.0M	$-96.0M	$-76.0M	$-99.0M
Financing Cash Flow	$-60.0M	$-40.0M	$-6.0M	$-2.0M	$-59.0M
Net Cash Flow	$-52.0M	$-8.0M	$-9.0M	$84.0M	$-80.0M
Free Cash Flow	$38.0M	$41.0M	$6.0M	$90.0M	$-6.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.29
EV / EBITDA	5.90
FCF Yield	-0.96%
Quick Ratio	1.24
Interest Coverage	0.79
Return 1Y	—
Return 3Y	—
Return 5Y	—

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ACRSAclaris Therapeutics, Inc.	$3.28	-6.02%	-8.88	$482.81M	0.00%
AGMBAgomAb Therapeutics NV - ADRs representing one common share.	$8.28	-0.60%	-9.33	$407.77M	0.00%
ALMSAlumis Inc.	$6.12	-3.01%	-1.80	$792.14M	0.00%
ANABAnaptysBio, Inc.	$46.61	-4.31%	7.19	$1.39B	0.00%
CNTBConnect Biopharma Holdings Limited	$0.91	+0.01%	-1.05	$57.07M	0.00%

About Attovia Therapeutics, Inc.

Attovia Therapeutics, Inc. is headquartered in LU.

Attovia Therapeutics, Inc. (ATTO) stock trades at $13.73 with a market capitalization of $626.79M. The stock is valued at a negative price-to-earnings (P/E) ratio of -23.81, reflecting a net loss over the last twelve months, price-to-book of 8.96, price-to-sales of 2117.08. Over the past 52 weeks the stock has ranged between $13.56 and $28.00, and currently trades 51.0% below its 52-week high.

On profitability, Attovia Therapeutics, Inc. generates a return on equity (ROE) of -32.05% (negative, reflecting a net loss), return on capital employed of 10.43%, an operating margin of 5.00%, a net profit margin of -6.21%.

Attovia Therapeutics, Inc. (ATTO) — frequently asked questions

What is Attovia Therapeutics, Inc. (ATTO) stock price today?

Attovia Therapeutics, Inc. (ATTO) is currently trading at $13.73, down 7.1% today.

What is ATTO P/E ratio?

Attovia Therapeutics, Inc.'s P/E ratio is -23.81. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.

What is ATTO return on equity (ROE)?

Attovia Therapeutics, Inc.'s return on equity (ROE) is -32.05%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.

What is Attovia Therapeutics, Inc.'s market cap?

Attovia Therapeutics, Inc. has a market capitalization of $626.79M.

Related Industrials Stocks

SPCX Space Exploration Technologies Corp. $146.03 -1.74% CAT Caterpillar, Inc. $730.76 -0.66% GE GE Aerospace $313.83 +0.59% RTX RTX Corporation $193.92 +3.73% DE Deere & Company $641.86 -1.35% UNP Union Pacific Corporation $289.04 +0.11% ETN Eaton Corporation, PLC $391.25 -2.79% BA Boeing Company (The) $190.21 +0.78% LMT Lockheed Martin Corporation $552.09 +3.65% PH Parker-Hannifin Corporation $963.34 +0.17% ADP Automatic Data Processing, Inc. $288.90 +1.14% TT Trane Technologies plc $458.89 +0.33%

Related stock screens

High ROE Industrials Stocks Low P/E Industrials Stocks High Net Margin Industrials Stocks Dividend Industrials Stocks Low Debt Industrials Stocks High ROE Stocks Low P/E Stocks High Net Margin Stocks Dividend Stocks Low Debt Stocks NYSE High ROE Stocks All stock screens

Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.